CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Functional Characterization Of 3D Assembled Neurospheres

  Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.

• Mobile Clinical Lab For Miami Cancer Institute

  Germfree helped the Miami Cancer Institute at the peak of the COVID pandemic convert a pharmacy compounding mobile unit to a BSL-2+ mobile clinical lab for in-house testing for COVID testing.

• Standardizing Cryopreservation For Cell Therapy Supply Chains

  Explore how a standardized cryopreservation process is transforming leukapheresis handling by reducing risk and improving quality across the cell therapy supply chain.

• Achieving Optimal CAR-T Cell Generation

  Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.

• The Advantages Of A Blended Learning Approach In Operator Training

  Explore blended learning and its advantages over traditional operator training methods, which often reduce training to a repetitive but necessary checklist of reading and acknowledging procedures.

• Accelerating The mAb Formulation Process

  Learn about a one-step process that was developed to streamline formulation, effectively reducing timelines from approximately 14 weeks to 8 weeks for this critical step.

• Delivering Specialist Neurology Support

  Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

• AAV Vectors In Gene Therapy Clinical Trials

  AAV-based gene therapies show promise but face immune challenges. ELISpot assays help evaluate T cell responses, enhancing clinical trial design and improving therapeutic success.

• A Scalable Manufacturing Platform For The Purification Of Stem Cell Derived Exosomes

  EV production scale increases require paired robust, scalable, and cost-effective downstream processes. Process parameters can be tailored for therapeutic exosome programs and allow for maximum exosome recovery.

• How Can I Increase My Viral Titers And Improve The Percentage Of Full AAVs?

  Explore various strategies to enhance viral titer and increase the percentage of full AAV capsids, like modifications to transfection reagents, cell lines, media, procedures, and more.